Berry Genomics Co Ltd (000710) — Cash Flow-to-Debt Ratio
Berry Genomics Co Ltd (000710) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-2.18 Million could theoretically repay 0% of its total liabilities (CN¥694.43 Million) in one year. See Berry Genomics Co Ltd (000710) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Berry Genomics Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Berry Genomics Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Berry Genomics Co Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Berry Genomics Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Berry Genomics Co Ltd. Check Berry Genomics Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥87.97 Million | CN¥669.56 Million | ▲ +0.2% |
| 2023 | 0.13x | CN¥111.01 Million | CN¥846.56 Million | ▲ +439.6% |
| 2022 | 0.02x | CN¥21.18 Million | CN¥871.54 Million | ▼ -74.3% |
| 2021 | 0.09x | CN¥94.03 Million | CN¥996.02 Million | ▼ -51.9% |
| 2020 | 0.20x | CN¥161.31 Million | CN¥821.52 Million | ▲ +15.2% |
| 2019 | 0.17x | CN¥123.06 Million | CN¥721.83 Million | ▼ -75.7% |
| 2018 | 0.70x | CN¥165.33 Million | CN¥235.68 Million | ▲ +132.0% |
| 2017 | 0.30x | CN¥74.35 Million | CN¥245.94 Million | ▲ +1024.5% |
| 2016 | -0.03x | CN¥-14.19 Million | CN¥433.97 Million | ▲ +82.4% |
| 2015 | -0.19x | CN¥-70.81 Million | CN¥381.19 Million | ▼ -410.2% |
| 2014 | 0.06x | CN¥18.91 Million | CN¥315.83 Million | ▲ +10.8% |
| 2013 | 0.05x | CN¥15.63 Million | CN¥289.09 Million | ▼ -75.7% |
| 2012 | 0.22x | CN¥48.27 Million | CN¥217.34 Million | ▲ +340.9% |
| 2011 | -0.09x | CN¥-21.46 Million | CN¥232.73 Million | ▼ -131.6% |
| 2010 | 0.29x | CN¥76.19 Million | CN¥261.04 Million | ▲ +3252.5% |
| 2009 | -0.01x | CN¥-2.33 Million | CN¥251.54 Million | ▼ -103.3% |
| 2008 | 0.28x | CN¥57.76 Million | CN¥206.93 Million | ▲ +680.6% |
| 2007 | 0.04x | CN¥4.70 Million | CN¥131.54 Million | ▼ -55.6% |
| 2006 | 0.08x | CN¥11.68 Million | CN¥144.87 Million | ▲ +43.8% |
| 2005 | 0.06x | CN¥7.58 Million | CN¥135.26 Million | ▲ +244.6% |
| 2004 | -0.04x | CN¥-6.43 Million | CN¥165.77 Million | ▼ -361.6% |
| 2003 | -0.01x | CN¥-1.23 Million | CN¥146.30 Million | ▼ -107.5% |
| 2002 | 0.11x | CN¥14.91 Million | CN¥133.22 Million | ▲ +125.7% |
| 2001 | -0.44x | CN¥-85.39 Million | CN¥195.81 Million | ▼ -565.4% |
| 2000 | -0.07x | CN¥-8.21 Million | CN¥125.33 Million | ▼ -133.3% |
| 1999 | 0.20x | CN¥15.30 Million | CN¥77.77 Million | ▼ -33.0% |
| 1998 | 0.29x | CN¥28.30 Million | CN¥96.34 Million | — |